GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (FRA:BSX) » Definitions » E10

Boston Scientific (FRA:BSX) E10 : €0.71 (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Boston Scientific E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Boston Scientific's adjusted earnings per share data for the three months ended in Dec. 2023 was €0.312. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.71 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Boston Scientific's average E10 Growth Rate was 21.20% per year. During the past 3 years, the average E10 Growth Rate was 61.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Boston Scientific was 81.70% per year. The lowest was -76.50% per year. And the median was 2.10% per year.

As of today (2024-04-30), Boston Scientific's current stock price is €68.00. Boston Scientific's E10 for the quarter that ended in Dec. 2023 was €0.71. Boston Scientific's Shiller PE Ratio of today is 95.77.

During the past 13 years, the highest Shiller PE Ratio of Boston Scientific was 415.18. The lowest was 58.68. And the median was 160.82.


Boston Scientific E10 Historical Data

The historical data trend for Boston Scientific's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific E10 Chart

Boston Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.15 0.21 0.61 0.71

Boston Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.68 0.74 0.71 -

Competitive Comparison of Boston Scientific's E10

For the Medical Devices subindustry, Boston Scientific's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Shiller PE Ratio falls into.



Boston Scientific E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Boston Scientific's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.312/129.4194*129.4194
=0.312

Current CPI (Dec. 2023) = 129.4194.

Boston Scientific Quarterly Data

per share eps CPI Adj_EPS
201403 0.072 99.695 0.093
201406 0.002 100.560 0.003
201409 0.023 100.428 0.030
201412 0.049 99.070 0.064
201503 -0.001 99.621 -0.001
201506 0.071 100.684 0.091
201509 -0.134 100.392 -0.173
201512 -0.101 99.792 -0.131
201603 0.135 100.470 0.174
201606 -0.134 101.688 -0.171
201609 0.151 101.861 0.192
201612 0.085 101.863 0.108
201703 0.196 102.862 0.247
201706 0.098 103.349 0.123
201709 0.168 104.136 0.209
201712 -0.380 104.011 -0.473
201803 0.170 105.290 0.209
201806 0.342 106.317 0.416
201809 0.266 106.507 0.323
201812 0.237 105.998 0.289
201903 0.266 107.251 0.321
201906 0.097 108.070 0.116
201909 0.082 108.329 0.098
201912 2.547 108.420 3.040
202003 0.009 108.902 0.011
202006 -0.098 108.767 -0.117
202009 -0.102 109.815 -0.120
202012 0.082 109.897 0.097
202103 0.193 111.754 0.224
202106 0.100 114.631 0.113
202109 0.238 115.734 0.266
202112 0.053 117.630 0.058
202203 0.064 121.301 0.068
202206 0.161 125.017 0.167
202209 0.121 125.227 0.125
202212 0.085 125.222 0.088
202303 0.196 127.348 0.199
202306 0.166 128.729 0.167
202309 0.319 129.860 0.318
202312 0.312 129.419 0.312

Add all the adjusted EPS together and divide 10 will get our e10.


Boston Scientific  (FRA:BSX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Boston Scientific's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=68.00/0.71
=95.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Boston Scientific was 415.18. The lowest was 58.68. And the median was 160.82.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Boston Scientific E10 Related Terms

Thank you for viewing the detailed overview of Boston Scientific's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Boston Scientific (FRA:BSX) Business Description

Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.